In addition, corylin significantly increased the expression of CD163 and CD206 (M2 markers) and reduced the expression of CD11b and CCR7 (M1 markers) as well as reversing the ratio of M1/M2 macrophages in AOM/DSS-treated mice (Figure 7A,B). The gene discussed is MRC1; the disease is infectious otitis media.